• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌:同一中心两个不同时期的比较。

Hepatocellular carcinoma: comparison of two different periods at the same center.

机构信息

Dipartimento di Medicina Clinica e delle Patologie Emergenti, Cattedra di Medicina Interna, Università di Palermo, Italy.

出版信息

Eur J Intern Med. 2010 Apr;21(2):127-30. doi: 10.1016/j.ejim.2009.12.011. Epub 2010 Jan 13.

DOI:10.1016/j.ejim.2009.12.011
PMID:20206885
Abstract

AIMS

To analyze the main etiological factors and some clinical characteristics of patients with HCC at diagnosis and to compare them with those we described ten years ago.

METHODS

179 patients were included in Group 1, while 132 patients were included in Group 2. For all patients age, sex, serum markers of hepatitis B and C viruses, alcohol consumption, serum alpha feto-protein (AFP) levels and the main liver function parameters at HCC diagnosis were recorded.

RESULTS

Mean age was 66.0 years for Group 1 and 69.0 for Group 2 (P=0.005). HCV was responsible for 80.3% of HCC cases in Group 2 versus 72% in Group 1 (P=0.005). HBV alone and co-infection of HCV+HBV decreased, but not significantly. In Group 1 only four patients had an underlying normal liver, while in Group 2 no patients showed an underlying normal liver (P=ns). HCC was more frequently associated with Child class A in Group 2 (P=0.0001), whereas in Group 1 it was more frequently associated with class C (P=0.0001). Staging of HCC correlated inversely when patients of Groups 1 and 2 were compared (P<0.03). AFP serum levels were above normal in 72% of cases in Group 1 and in 41.5% in Group 2 (P=0.0001).

CONCLUSION

This study shows that over the last decade a number of characteristics of patients with HCC in our region have changed, particularly age at onset of HCC, staging of underlying liver disease and staging of HCC.

摘要

目的

分析诊断为 HCC 的患者的主要病因学因素和一些临床特征,并将其与我们十年前描述的特征进行比较。

方法

将 179 例患者纳入第 1 组,132 例患者纳入第 2 组。记录所有患者的年龄、性别、乙型肝炎和丙型肝炎病毒血清标志物、饮酒情况、血清甲胎蛋白(AFP)水平以及 HCC 诊断时的主要肝功能参数。

结果

第 1 组的平均年龄为 66.0 岁,第 2 组为 69.0 岁(P=0.005)。第 2 组中 80.3%的 HCC 病例由 HCV 引起,而第 1 组中这一比例为 72%(P=0.005)。HBV 单独感染和 HCV+HBV 合并感染减少,但无统计学意义。第 1 组中只有 4 例患者存在基础正常肝脏,而第 2 组中没有患者存在基础正常肝脏(P=无统计学意义)。第 2 组 HCC 更常与 Child 分级 A 相关(P=0.0001),而第 1 组 HCC 更常与 Child 分级 C 相关(P=0.0001)。第 1 组和第 2 组患者比较时,HCC 分期呈负相关(P<0.03)。第 1 组中 72%的病例 AFP 血清水平高于正常值,而第 2 组中这一比例为 41.5%(P=0.0001)。

结论

本研究表明,在过去十年中,我们地区 HCC 患者的一些特征发生了变化,特别是 HCC 发病年龄、基础肝病分期和 HCC 分期。

相似文献

1
Hepatocellular carcinoma: comparison of two different periods at the same center.肝细胞癌:同一中心两个不同时期的比较。
Eur J Intern Med. 2010 Apr;21(2):127-30. doi: 10.1016/j.ejim.2009.12.011. Epub 2010 Jan 13.
2
[Variable clinical symptoms of hepatocellular carcinoma].[肝细胞癌的临床症状多样]
Dtsch Med Wochenschr. 1988 Feb 26;113(8):294-6. doi: 10.1055/s-2008-1067633.
3
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.肝硬化病因对监测期间诊断为肝细胞癌患者生存的影响。
Am J Gastroenterol. 2007 May;102(5):1022-31. doi: 10.1111/j.1572-0241.2007.01100.x. Epub 2007 Feb 21.
4
Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.意大利肝细胞癌病因中的肝炎病毒、酒精和烟草。
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):683-9. doi: 10.1158/1055-9965.EPI-05-0702.
5
[Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].[德国的肝细胞癌。一所大学诊所100例连续患者的流行病学、病因、临床情况及预后]
Z Gastroenterol. 1997 Dec;35(12):1059-67.
6
Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.肝细胞癌的临床病理特征及危险因素:来自土耳其南部一个中心的结果
Turk J Gastroenterol. 2003 Jun;14(2):85-90.
7
[Screening for hepatocellular carcinoma].[肝细胞癌筛查]
Minerva Med. 2005 Apr;96(2):95-108.
8
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.意大利有肝硬化和无肝硬化的肝细胞癌患者的病因
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):213-6.
9
Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C-associated hepatocellular carcinoma in Thailand.泰国乙型肝炎和丙型肝炎相关肝细胞癌患者的临床特征与生存情况比较。
J Med Assoc Thai. 2003 Jun;86 Suppl 2:S250-6.
10
[Primary hepatocellular carcinoma. Relation between serum and liver alpha fetoprotein, B virus infection, histology].[原发性肝细胞癌。血清与肝脏甲胎蛋白、B病毒感染及组织学之间的关系]
Minerva Dietol Gastroenterol. 1985 Oct-Dec;31(4):627-33.

引用本文的文献

1
Coinfection of Hepatitis B and C Viruses and Risk of Hepatocellular Carcinoma: Systematic Review and Meta-analysis.乙型肝炎病毒与丙型肝炎病毒合并感染及肝细胞癌风险:系统评价与荟萃分析
J Glob Infect Dis. 2024 Dec 21;16(4):127-134. doi: 10.4103/jgid.jgid_211_23. eCollection 2024 Oct-Dec.
2
Changes in the ultrasound presentation of hepatocellular carcinoma: a center's three decades of experience.肝细胞癌的超声表现变化:一个中心三十年的经验。
J Ultrasound. 2024 Jun;27(2):383-391. doi: 10.1007/s40477-024-00888-7. Epub 2024 Apr 7.
3
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center.
肝细胞癌的流行病学变化:单中心经验。
Biomed Res Int. 2020 Feb 27;2020:5309307. doi: 10.1155/2020/5309307. eCollection 2020.
4
New landscapes and horizons in hepatocellular carcinoma therapy.肝细胞癌治疗的新领域和新前景。
Aging (Albany NY). 2020 Feb 4;12(3):3053-3094. doi: 10.18632/aging.102777.
5
Surveillance Program for Diagnosis of HCC in Liver Cirrhosis: Role of Ultrasound Echo Patterns.肝硬化肝癌诊断的监测方案:超声回声模式的作用。
Biomed Res Int. 2017;2017:4932759. doi: 10.1155/2017/4932759. Epub 2017 May 30.
6
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population.PNPLA3和GRP78基因变异与意大利人群肝细胞癌发生风险的关联
Oncotarget. 2016 Dec 27;7(52):86791-86802. doi: 10.18632/oncotarget.13558.
7
Non invasive tools for the diagnosis of liver cirrhosis.用于诊断肝硬化的非侵入性工具。
World J Gastroenterol. 2014 Dec 28;20(48):18131-50. doi: 10.3748/wjg.v20.i48.18131.
8
Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?奥地利肝细胞癌患者的临床特征——是否需要有组织的筛查计划?
Wien Klin Wochenschr. 2011 Sep;123(17-18):542-51. doi: 10.1007/s00508-011-0033-9. Epub 2011 Jul 29.